GOLDMAN SACHS GROUP INC - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 78 filers reported holding PDS BIOTECHNOLOGY CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$67,276
-51.7%
13,322
-51.9%
0.00%
Q2 2023$139,321
-73.4%
27,698
-67.5%
0.00%
Q1 2023$523,802
+184.7%
85,171
+186.3%
0.00%
Q1 2022$184,000
-28.4%
29,752
-6.3%
0.00%
Q4 2021$257,000
+51.2%
31,762
+178.7%
0.00%
Q3 2021$170,000
+78.9%
11,395
-45.4%
0.00%
Q1 2021$95,000
+126.2%
20,867
+6.5%
0.00%
Q4 2020$42,00019,6000.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q3 2023
NameSharesValueWeighting ↓
INSPIRION WEALTH ADVISORS, LLC 330,874$1,670,9140.33%
TANG CAPITAL MANAGEMENT LLC 400,000$2,020,0000.28%
Iron Gate Global Advisors LLC 75,016$377,3300.08%
Nebula Research & Development LLC 25,708$129,8250.07%
Corton Capital Inc. 22,091$111,5600.06%
Sofinnova Investments, Inc. 142,635$720,3070.04%
LAZARI CAPITAL MANAGEMENT, INC. 11,000$55,5500.03%
OCCUDO QUANTITATIVE STRATEGIES LP 24,369$123,0630.02%
WINTON GROUP Ltd 21,256$107,3430.01%
Truvestments Capital LLC 1,372$6,9290.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders